Newamsterdam pharma reports full year 2024 financial results and provides corporate update

-- ema submission expected in 2h25 by partner menarini -- -- additional data from broadway, brooklyn, and tandem to be presented throughout 2025 --
NAMS Ratings Summary
NAMS Quant Ranking